Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dalargin for Prevention of Postoperative Organ Dysfunction in High-Risk Abdominal Surgery
NCT07404358Phase 3Completed
- Sponsor
- Botkin Hospital
- Start
- May 2025
- Primary completion
- Sep 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of dalargin in postoperative complications, multiple organ dysfunction syndrome (MODS), sponsored by Botkin Hospital. Started May 2025; status: completed.
02
Drugs
dalargin
03
Conditions
postoperative complicationsmultiple organ dysfunction syndrome (MODS)
Beyond the preview
Go deeper on NCT07404358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07404358.